The news on Gilead Sciences
ShareThere has been 20 news on Gilead Sciences in the past from 7 different sources and amongst 2 sections.
Full access to all news in this scope:
See the trend on this scope:
Evolution through time
Latest news
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Here are Monday's biggest analyst calls: Nvidia, Apple, Amazon, Netflix, Campbell Soup, Gilead, American Express & more
Gilead's tie up with generic cos may not address HIV challenge
Dr Reddy's, Hetero ink royalty-free pact with Gilead
Dr Reddy's, Hetero ink royalty-free voluntary licencing pacts with Gilead Sciences for HIV drug Lenacapavir
Gilead says its twice-yearly shot cut HIV infections by 96% in trial
Gilead Sciences alleges dangerous drug-counterfeiting operation at two NYC pharmacies in lawsuit
Activists Challenge Pharma Company Gilead Over HIV Medication
Stocks making the biggest moves premarket: Gilead Sciences, Sarepta Therapeutics, Nike and more
Stocks making the biggest moves midday: Gilead Sciences, Accenture, Trump Media, AMD and more
CymaBay shares jumped nearly 25% to hit a record after the clinical-stage biopharmaceutical company agreed to be acquired by Gilead for $4.3 billion.
CymaBay Therapeutics Shares Hit All-Time High on Gilead Deal
Stocks making the biggest moves midday: Vita Coco, Archer-Daniels-Midland, Gilead Sciences and more
Sections
The coverage spreads amongst 2 sections:
Sources
There has been 7 news sources reporting on this, including: CNBC News (40%), Times of India (20%), The Wall Street Journal (15%), Quartz (10%), The New York Times (5%).
Going further
Stay up to date:
Details
This content can be used under the CC BY 4.0 license
